Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
23.05.24
/
50%
€44.80
Target price
23.05.25
€64.64
Performance (%)
2.68%
Price
05.09.24
€46.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 2.68%. This prediction currently runs until 23.05.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | -3.361% | -3.361% |
iShares Core DAX® | -1.414% | 7.218% |
iShares Nasdaq 100 | -2.316% | 4.450% |
iShares Nikkei 225® | -2.756% | 10.071% |
iShares S&P 500 | -1.849% | 4.760% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Morgan Stanley from $50.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat